[HTML][HTML] Antibiotic-induced gut dysbiosis and cognitive, emotional, and behavioral changes in rodents: a systematic review and meta-analysis

SS Hayer, S Hwang, JB Clayton - Frontiers in Neuroscience, 2023 - frontiersin.org
There are previous epidemiological studies reporting associations between antibiotic use
and psychiatric symptoms. Antibiotic-induced gut dysbiosis and alteration of microbiota-gut …

Decoding the role of the gut microbiome in gut-brain axis, stress-resilience, or stress-susceptibility: A review

RK Sah, A Nandan, S Prashant… - Asian Journal of …, 2023 - Elsevier
Increased exposure to stress is associated with stress-related disorders, including
depression, anxiety, and neurodegenerative conditions. However, susceptibility to stress is …

[HTML][HTML] The gut microbiome regulates astrocyte reaction to Aβ amyloidosis through microglial dependent and independent mechanisms

S Chandra, A Di Meco, HB Dodiya, J Popovic… - Molecular …, 2023 - Springer
Background Previous studies show that antibiotic-mediated (abx) alteration of the gut
microbiome (GMB) results in a reduction of amyloid beta (Aβ) plaques and proinflammatory …

Multi-omics data reveals aberrant gut microbiota-host glycerophospholipid metabolism in association with neuroinflammation in APP/PS1 mice

X Qian, W Hai, S Chen, M Zhang, X Jiang, H Tang - Gut Microbes, 2023 - Taylor & Francis
Numerous studies have described the notable impact of gut microbiota on the brain in
Alzheimer's disease (AD) via the gut–brain axis. However, the molecular mechanisms …

[HTML][HTML] The antimicrobial properties of cannabis and cannabis-derived compounds and relevance to CB2-targeted neurodegenerative therapeutics

HJ Hong, L Sloan, D Saxena, DA Scott - Biomedicines, 2022 - mdpi.com
Cannabinoid receptor 2 (CB2) is of interest as a much-needed target for the treatment or
prevention of several neurogenerative diseases. However, CB2 agonists, particularly …

Evolving therapeutic interventions for the management and treatment of Alzheimer's disease

F Ahmad, A Karan, R Sharma, NS Sharma… - Ageing research …, 2024 - Elsevier
Alzheimer's Disease (AD) patients experience diverse symptoms, including memory loss,
cognitive impairment, behavioral abnormalities, mood changes, and mental issues. The …

[HTML][HTML] Gut microbiota, pathogenic proteins and neurodegenerative diseases

W Wei, S Wang, C Xu, X Zhou, X Lian, L He… - Frontiers in …, 2022 - frontiersin.org
As the world's population ages, neurodegenerative diseases (NDs) have brought a great
burden to the world. However, effective treatment measures have not been found to alleviate …

[HTML][HTML] Association between mild cognitive impairment and gut microbiota in elderly Korean patients

EJ Kim, JS Kim, SE Park, SH Seo, KM Cho… - … of Microbiology and …, 2023 - ncbi.nlm.nih.gov
Recent studies have confirmed that gut microbiota differs according to race or country in
many diseases, including mild cognitive impairment (MCI) and Alzheimer's disease …

[HTML][HTML] Bacterial DNAemia in alzheimer's disease and mild cognitive impairment: association with cognitive decline, plasma BDNF levels, and inflammatory response

R Giacconi, P D'Aquila, M Balietti, C Giuli… - International Journal of …, 2022 - mdpi.com
Microbial dysbiosis (MD) provokes gut barrier alterations and bacterial translocation in the
bloodstream. The increased blood bacterial DNA (BB-DNA) may promote peripheral-and …

Microbiota–gut–brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control

J Li, F Zhang, L Zhao, C Dong - Reviews in the Neurosciences, 2023 - degruyter.com
Alzheimer's disease (AD) is the most common type of dementia in the elderly and causes
neurodegeneration, leading to memory loss, behavioral disorder, and psychiatric …